The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.
from Latest Science News -- ScienceDaily https://ift.tt/2ObI7k3
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment